Finance

Consumer Goods Consumer Services Economy Energy Finance Health Care How To Invest Industrials Materials

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology...

HAMPTON, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today the presentation of long-term results from the Phase 2 study of barzolvolimab in a flash talk session at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting in Istanbul, Türkiye. The data presented demonstrated that barzolvolimab treatment results in rapid, significant, and durable improvements in angioedema in patients with chronic spontaneous urticaria (CSU) refractory to antihistamines. These results were sustained off-treatment, seven months after completion of barzolvolimab dosing (Week 76). The data continue to demonstrate barzolvolimab’s potential to shift the goal of CSU treatment from symptom control to disease modification and further support the ongoing Phase 3 trials of barzolvolimab in CSU.

Health Care globenewswire -

Orbis International’s Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care

With support from Alcon, FedEx, and OMEGA, the Orbis Flying Eye Hospital returns to Peru to...

Health Care prnewswire -

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

– Lorundrostat was associated with significant reductions in heart failure risk biomarkers in a proteomic analysis of data from participants with uncontrolled hypertension –

Health Care globenewswire -

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically...

Energy prnewswire -

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON

NEW YORK, June 14, 2026 /PRNewswire/ -- ...

Finance prnewswire -

Latest

Veritone, Inc. (VERI) Securities Class Action Filed After Admitting Improper Revenue Accounting – HBSS

SAN FRANCISCO, June 9, 2026 /PRNewswire/ -- Veritone, Inc. (NASDAQ: VERI) faces a securities class action lawsuit, which seeks to represent investors who purchased...

73% of U.S. Workers Would Sacrifice Pay for Workplace Wellbeing

A PensionBee survey of 1,000 U.S. workers revealed a critical flaw in benefits delivery: offboarding guidance is significantly weaker than onboarding.

Cetera Welcomes Former Commonwealth Advisors David Cushard, Wesley Mullins, and Their Team, with Approximately $190 Million in AUA

After a deliberate search for the Commonwealth experience, experienced advisors find their answer inCetera's unique Summit communitySAN DIEGO, June 9, 2026 /PRNewswire/ -- Cetera welcomes...

Notice of Extraordinary General Meeting of Jyske Realkredit A/S on Thursday, June 25, 2026, at 7:30 a.m. at the company’s address: Kalvebod Brygge 3,...

To Nasdaq Copenhagen A/S June 9, 2026
Announcement No. 48/2026

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomePress ReleasesFinance

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology...

Orbis International’s Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Finance

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology...

Orbis International’s Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON

Veritone, Inc. (VERI) Securities Class Action Filed After Admitting Improper Revenue Accounting – HBSS

73% of U.S. Workers Would Sacrifice Pay for Workplace Wellbeing

Cetera Welcomes Former Commonwealth Advisors David Cushard, Wesley Mullins, and Their Team, with Approximately $190 Million in AUA

Notice of Extraordinary General Meeting of Jyske Realkredit A/S on Thursday, June 25, 2026, at 7:30 a.m. at the company’s address: Kalvebod Brygge 3,...

The Hainan Payment Service Electronic Map is now online

Aktsiaselts Infortar omandas täiendava osaluse Aktsiaseltsis Tallink Grupp

Cariqa launches Connect API, the world’s first direct payment API for EV charging

Form 8.5 (EPT/RI) – PPHE Hotel Group Ltd

CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES

OpenWay collaborates with Visa to help banks launch new payment products at speed and scale

OHS opens 327,000 sq ft Trafford Park fulfilment centre to support rapid growth

Progress on share buyback programme

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

KT&G: “U.S. investor Capital Research and Management Company Increases stake from 5.6% to 7.2%”

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us